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Balancing treatment allocation for influential covariates is critical
in clinical trials. This has become increasingly important as more and
more biomarkers are found to be associated with different diseases
in translational research (genomics, proteomics and metabolomics).
Stratified permuted block randomization and minimization methods
[Pocock and Simon Biometrics 31 (1975) 103–115, etc.] are the two
most popular approaches in practice. However, stratified permuted
block randomization fails to achieve good overall balance when the
number of strata is large, whereas traditional minimization methods
also suffer from the potential drawback of large within-stratum im-
balances. Moreover, the theoretical bases of minimization methods
remain largely elusive. In this paper, we propose a new covariate-
adaptive design that is able to control various types of imbalances.
We show that the joint process of within-stratum imbalances is a posi-
tive recurrent Markov chain under certain conditions. Therefore, this
new procedure yields more balanced allocation. The advantages of
the proposed procedure are also demonstrated by extensive simula-
tion studies. Our work provides a theoretical tool for future research
in this area.
1. Introduction. In clinical trials, covariates are factors that have a large
impact on the responses of the patients. Typical covariates include gender,
age, disease stage, different research center, etc. At the design stage it is often
important to balance treatment allocation over covariates, as a well-balanced
trial can lead to more efficient statistical comparison and more convincing
results to the general audience [Kundt (2009)]. Balanced allocation is also
particularly useful when the sample size is small or when interim analysis
or subgroup analysis is desired [Toorawa et al. (2009)].
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Stratified randomization is a popular way of achieving balance. It defines
strata as different combinations of the covariates’ levels and employs per-
muted block randomization within each stratum. This method is easy to
implement and achieves good balance when the number of strata is small
[Kalish and Begg (1985)]. However, the permuted block design is susceptible
to selection bias [Matts and Lachin (1988)]. Moreover, it tends to cause se-
vere allocation imbalance in the whole trial when there are too many strata,
typically as a result of many covariates, or many levels within the individual
covariates [Pocock (1982)]. Increasing numbers of strata, however, has be-
come the trend, due to the need to conduct multicenter trials as well as the
inclusion of newly identified biomarkers as covariates [Khan et al. (2010), Li
et al. (2010), McIlroy et al. (2010), etc.].
Covariate-adaptive randomization (or minimization) has been proposed to
address the above problem. The earliest work on minimization dates back
to Taves (1974) and Pocock and Simon (1975). In particular, with I be-
ing the number of covariates and mi the number of levels for covariate i,
i = 1, . . . , I , Pocock and Simon’s (1975) procedure minimizes a weighted
average of marginal imbalances
∑
iwidi(n), where di(n) is a measure of im-
balance among treatment groups with respect to the ith margin of the new
patient. Simulation studies [Weir and Lees (2003), Toorawa et al. (2009),
Kundt (2009)] found that this method reduces marginal imbalances as well
as the overall imbalance. Wei (1978) generalized Taves’s method by intro-
ducing a marginal urn model. Other works include Zelen (1974), Nordle
and Brantmark (1977), Signorini et al. (1993) and Heritier, Gebski and Pil-
lai (2005), which used a hierarchical decision rule and set priority among
elements of strata, margins and overall trial. Despite the numerous works
in the literature, “very little is known about the theoretical properties of
covariate-adaptive designs” [Rosenberger and Sverdlov (2008)].
Model-based approach was introduced by Begg and Iglewicz (1980) and
Atkinson (1982), and the theoretical work has been developed by Smith
(1984a, 1984b). Smith considered the linear model Eyn = Tnα+
∑p
j=1 zn,jβj
with homogeneous errors and no interaction of any type, where yn, Tn,
(zn,1, . . . , zn,p) are the response, assignment and covariate values of the nth
patient, respectively, and Tn = +1 or −1 for treatment 1 or 2. Since α,
the treatment effect, is the main interest of the trial, this method sequen-
tially skews the allocation probability toward the treatment that would lead
to a smaller variance of αˆ (the MLE of α). Under some appropriate al-
location functions Smith derived the asymptotic normality of
∑n
i=1 zi,jTi
(j = 1, . . . , p). This asymptotic property was further applied to the construc-
tion of a conditional permutation test [Smith (1984b)].
Although the minimization approach [Pocock and Simon (1975), Wei
(1978), etc.] and the model-based approach [Smith (1984a, 1984b), etc.]
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both lead to marginal and overall balance, they are rather different in na-
ture. First, even if they use the same biased coin function, the two allocation
rules are still not the same, unless in the trivial case of no covariates. Hence
Smith’s asymptotic result does not readily apply to Pocock and Simon’s or
Wei’s procedure. Second, Smith’s result depends on the homogeneous linear
model. Therefore, once the data type has changed (such as binary or sur-
vival responses), model-based approach does not necessarily imply balance.
Finally, minimization approach is more popular in practice [Taves (2010)].
In fact, as discussed by many authors such as Lagakos and Pocock (1984),
Smith (1984b) and McEntegart (2003), balanced allocation enhances cred-
ibility of the trials for medical professions that are less statistically sophis-
ticated, and the simple comparisons of similar groups of patients are often
more acceptable than a model-based approach adjusting for covariates.
In this paper we focus on the minimization approach that compares pa-
tient numbers at different levels. While the marginal procedures have good
balance with respect to the margins and the whole trial, their performance
within the individual strata is not as satisfactory [Signorini et al. (1993),
Kundt (2009)]. Wei (1978) gave a short proof that if no interaction exists,
marginal balances are sufficient to ensure unbiased estimation of treatment
effect in an unadjusted analysis. In other words, when interactions do ex-
ist, ignorance of within-stratum imbalances may lead to biased estimation.
Moreover, as the field of personalized medicine develops [Hu (2012)], sub-
group analysis is often desired, and allocation balance within individual
strata can improve the precision of such analysis.
To overcome the potential drawbacks of stratification and Pocock and Si-
mon’s (1975) method, we develop a new randomization procedure in this pa-
per, which considers a weighted average of three types of imbalances (within-
stratum, within-covariate-margin and overall). By adopting Efron’s (1971)
discrete allocation function, the next patient will be assigned with higher
probability to a treatment that leads to a smaller value of the weighted
average.
To study the theoretical properties of the new procedure, the main dif-
ficulties include the correlation structure of within-stratum imbalances as
well as the discreteness of the allocation function. In the literature, a large
number of adaptive designs adopt a continuous allocation function, and their
properties are often obtained by a Taylor expansion of the allocation func-
tion, accompanied by a martingale approximation [Bai and Hu (1999), Hu
and Zhang (2004), Zhang, Hu and Cheung (2006), etc.]. Since we use Efron’s
function, which is discrete at 0, the Taylor expansion is not feasible. We seek
to take advantage of an alternative technique, namely “drift conditions,”
which was developed to study the stability of Markov chains on general
state spaces. We show that the joint process of within-stratum imbalances
under the new procedure is a positive recurrent Markov chain under some
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conditions, and thus preserves the order of Op(1) at the within-stratum level.
Our simulations suggest that the within-stratum imbalances under Pocock
and Simon’s (1975) design have fast-increasing variances as sample size in-
creases, implying a slower rate than Op(1).
In Section 2, the new procedure is described in general with I covariates.
The theoretical results of the new procedure are given in Section 3. We
further use simulations to study the different covariate-adaptive designs in
Section 4 and conclude our paper with some observations in Section 5. The
proofs of the theorems can be found in Section 6 and the supplemental article
[Hu and Hu (2012)].
2. The new covariate-adaptive randomization procedure. This setting is
similar to that of Pocock and Simon (1975), except that we only focus on
two treatment groups, 1 and 2. Consider I covariates and mi levels for the
ith covariate, resulting in m=
∏I
i=1mi strata. Let Tj be the assignment of
the jth patient, j = 1, . . . , n, that is, Tj = 1 for treatment 1 and Tj = 0 for
treatment 2. Let Zj indicate the covariate profile of that patient, that is,
Zj = (k1, . . . , kI) if his or her ith covariate is at level ki, 1 ≤ i≤ I and 1≤
ki ≤mi. For convenience, we use (k1, . . . , kI) to denote the stratum formed
by patients who possess the same covariate profile (k1, . . . , kI), and use (i;ki)
to denote the margin formed by patients whose ith covariate is at level ki.
The new procedure is defined as follows:
(1) The first patient is assigned to treatment 1 with probability 1/2.
(2) Suppose (n− 1) patients have been assigned to a treatment (n > 1) and
the nth patient falls within stratum (k∗1 , . . . , k
∗
I ).
(3) For the first (n− 1) patients:
- let Dn−1 be the difference between the numbers of patients in treat-
ment group 1 and 2 as total, that is, the number in group 1 minus
the number in group 2;
- similarly, let Dn−1(i;k
∗
i ) and Dn−1(k
∗
1 , . . . , k
∗
I ) be the differences be-
tween the numbers of patients in the two treatment groups on the
margin (i;k∗i ), and within the stratum (k
∗
1 , . . . , k
∗
I ), respectively;
- these differences can be positive, negative or zero, and each one is
used to measure the imbalance at the corresponding level (overall,
marginal, or within-stratum).
(4) If the nth patient were assigned to treatment 1, then D
(1)
n =Dn−1 + 1
would be the “potential” overall difference in the two groups; similarly,
D(1)n (i;k
∗
i ) =Dn−1(i;k
∗
i ) + 1
and
D(1)n (k
∗
1 , . . . , k
∗
I ) =Dn−1(k
∗
1, . . . , k
∗
I ) + 1
would be the potential differences on margin (i;k∗i ) and within stratum
(k∗1 , . . . , k
∗
I ), respectively.
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(5) Define an imbalance measure Imb
(1)
n by
Imb(1)n =wo[D
(1)
n ]
2 +
I∑
i=1
wm,i[D
(1)
n (i;k
∗
i )]
2 +ws[D
(1)
n (k
∗
1 , . . . , k
∗
I )]
2,
which is the weighted imbalance that would be caused if the nth patient
were assigned to treatment 1. wo, wm,i and ws are nonnegative weights
placed overall, within a covariate margin and within a stratum cell,
respectively. Without loss of generality we can assume
wo +ws +
I∑
i=1
wm,i = 1.
(6) In the same manner we can define Imb
(2)
n , the weighted imbalance that
would be caused if the nth patient were assigned to treatment 2. In this
case, the three types of potential differences are the existing ones minus
1, instead of plus 1.
(7) Conditional on the assignments of the first (n − 1) patients as well as
the covariates’ profiles of the first n patients, assign the nth patient to
treatment 1 with probability
P (Tn = 1|Zn,Tn−1) =


q, if Imb
(1)
n > Imb
(2)
n ,
p, if Imb
(1)
n < Imb
(2)
n ,
0.5, otherwise,
where n > 1, 0 < q < p < 1, p + q = 1, Zn = (Z1, . . . ,Zn) and Tn−1 =
(T1, . . . , Tn−1).
Remark 2.1. When wo =ws = 0, that is, only the marginal imbalances
are considered, the proposed design reduces to a special case of Pocock and
Simon’s (1975) method; and when wm,i = wo = 0, it reduces to stratified
randomization, where a separate biased coin is employed to determine the
assignment within each stratum. However, we will explore procedures with
other choices of weights, to see if they can lead to more balanced allocation
from various perspectives.
Remark 2.2. In the literature different views have been given as to the
selection of the biasing probability p. Efron (1971) suggested p = 2/3, but
his method does not consider covariates. The more recent papers, especially
those involving covariate-adaptive randomization, suggested larger p’s, such
as 0.85, 0.90 and 0.95. See Weir and Lees (2003), Hagino et al. (2004),
Toorawa et al. (2009), and Hu, Zhang and He (2009). One may also use other
generators in step (7), for example, Wei’s (1978) generator. The properties
of the design will be different.
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Table 1
An example illustrating the calculation under the new procedure
D50(·) D
(1)
51 (·) = D50(·)+1 D
(2)
51 (·) =D50(·)− 1
Overall 0 1 −1
Margin of male (1;1) 0 1 −1
Margin of smokers (2;1) −1 0 −2
Stratum of male smoker (1,1) −2 −1 −3
Example 1. Suppose in a trial two covariates, gender and smoking be-
havior, are considered to be influential, each of which has two levels. Thus,
the 4 strata (1,1), (1,2), (2,1), (2,2) represent male smokers, male nonsmok-
ers, female smokers and female nonsmokers, respectively. Assume that the
weights are wo = 1/3, wm,1 =wm,2 = 1/6 and ws = 1/3. The first 50 patients
have been randomized and the 4 within-stratum differences among these 50
patients are −2, +2, +1 and −1. If the 51th patient is a male smoker, then
the current imbalances are calculated as:
- overall: Dn−1 =−2 + 2+ 1− 1 = 0;
- margin of male: Dn−1(1; 1) =−2 + 2 = 0;
- margin of smokers: Dn−1(2; 1) =−2 + 1 =−1;
- stratum of male smokers: Dn−1(1,1) =−2.
The potential imbalances if the new patient were assigned to treatment 1
or 2 are given in Table 1.
Therefore,
Imb
(1)
51 = (1)
2 · 13 + (1)
2 · 16 + (0)
2 · 16 + (−1)
2 · 13 = 0.83,
Imb
(2)
51 = (−1)
2 · 13 + (−1)
2 · 16 + (−2)
2 · 16 + (−3)
2 · 13 = 4.17.
Since Imb
(1)
51 = 0.83< Imb
(2)
51 = 4.17, the coin will be biased toward treatment
1 with probability p > 0.5.
3. Theoretical properties of the new design. We now investigate the
asymptotic properties of the proposed design. For the first n patients, we
know that Dn(k1, . . . , kI) is the true difference of patient numbers within
stratum (k1, . . . , kI). Furthermore, let
Dn = [Dn(k1, . . . , kI)]1≤k1≤m1,...,1≤kI≤mI
be an array of dimension m1 × · · · ×mI which stores the current assign-
ment differences in all strata. Also, assume that the covariates Z1,Z2, . . .
are independently and identically distributed. Since Zn = (k1, . . . , kI) can
take m=
∏I
i=1mi different values, it in fact follows an m-dimension multi-
nomial distribution with parameter p= (p(k1, . . . , kI)), each element being
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the probability that a patient falls within the corresponding stratum. Obvi-
ously, p(k1, . . . , kI)≥ 0 and
∑
k1,...,kI
p(k1, . . . , kI) = 1.
First, we notice that (Dn)n≥1 is a Markov chain on the space Z
m. In fact,
by definition of the new procedure, Dn is a function f of (Dn−1,Zn, Tn).
Moreover, conditional on Dn−1, (Zn, Tn) is independent of (D1, . . . ,Dn−2);
therefore,Dn = f(Dn−1,Zn, Tn) is also conditionally independent of (D1, . . . ,
Dn−2).
We next explore the conditions under which (Dn)n≥1 is a positive recur-
rent chain, a desired property which indicates fast convergence rate. We will
first investigate the special case of 2× 2 strata, that is, only two covariates
and two levels for each. This case enables us to obtain a finer result than the
more general case, and at the same time also sheds light on how to set the
conditions for the latter. With 2× 2 strata, the weights on Imb
(1)
n or Imb
(2)
n
reduce to wo, wm,1, wm,2 and ws.
Theorem 3.1. For the new design, consider 2 covariates and 2 levels for
each. wo, wm,1, wm,2 and ws are nonnegative with wo+wm,1+wm,2+ws = 1.
If the following two conditions hold:
(A) ws > 0,
(B) define
u1 = wo +wm,1 +wm,2 +ws = 1,
u2 = wo +wm,1,
u3 = wo +wm,2,
u4 = wo;
the solution x= (x1, x2, x3) to the linear equation
u1 u2 u3u2 u1 u4
u3 u4 u1



x1x2
x3

=

u4u3
u2


satisfies |x1|+ |x2|+ |x3|< 1,
then (Dn)n≥1 is a positive recurrent Markov chain with period 2 on Z
4.
Remark 3.1. By Theorem 3.1 the chains D2n+1 and D2n are two er-
godic chains and converge to two limit distributions, respectively. Thus,
D2n+1 = Op(1) and D2n = Op(1), which implies that Dn = Op(1). Accord-
ingly, the imbalances at any level (within strata, on the margins, or overall)
preserve the order of Op(1).
Remark 3.2. In fact, u1, u2, u3 and u4 in the above theorem can be
interpreted as the weights placed on individual strata: call the stratum in
which the current patient falls a “target,” then u1 is the weight on the
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Table 2
Constraint on wm as a function of wo
wo 0.00 0.20 0.40 0.60 0.80
C(wo) 0.31 0.23 0.17 0.11 0.05
target itself; u2 (u3) on any stratum that is at the same level of covariate 1
(covariate 2) as the target; u4 on any of the remaining strata.
Corollary 3.1. In Theorem 3.1, if we further assume that wm,1 =
wm,2 :=wm, then condition (B) is equivalent to
wm <C(wo) :=
√
(1−wo)2 +4(1 +wo)2 − 1− 3wo
4
.(B′)
Remark 3.3. See Table 2 for certain values of C(wo). Since C(wo) is
a decreasing and almost linear function of wo on [0,1], condition (B
′) is
much easier to verify than condition (B). For example, if the weight at the
overall level wo = 0.20, then the ones on the two margins need to be less than
0.23. Therefore, (wo,wm,1,wm,2,ws) = (0.20,0.22,0.22,0.36) is a legitimate
weight set that ensures positive recurrence.
The next theorem deals with the general case of m =
∏I
i=1mi strata.
Using the basic equation (x + 1)2 − (x − 1)2 = 4x, the critical quantity
Imb
(1)
n − Imb
(2)
n in step (7) (Section 2) can be simplified as
Imb(1)n − Imb
(2)
n
= 4
{
woDn−1 +
I∑
i=1
wm,iDn−1(i;k
∗
i ) +wsDn−1(k
∗
1, . . . , k
∗
I )
}
(3.1)
:= 4 · δn−1(k
∗
1 , . . . , k
∗
I ).
Therefore, the biasing probability p, q or 1/2 is determined by the sign of
δn−1(k
∗
1 , . . . , k
∗
I ), which is a weighted average of current imbalances at differ-
ent levels. Since Dn−1 and Dn−1(i;k
∗
i ) can both be expressed as a sum
of certain Dn−1(k1, . . . , kI)’s, we want to reformulate δn−1(k
∗
1, . . . , k
∗
I ) as
a weighted average of imbalances within the individual strata.
As a motivating example, consider 3 covariates, gender (male or female),
smoking behavior (smoker or nonsmoker) and clinical center (3 centers), with
a total of 12 strata. Suppose for the new patient Zn = (1,1,1), that is, he
falls into the stratum of “male smokers at center 1.” Then for the remaining
strata, the weights on Dn−1(k1, . . . , kI)’s in the expression of δn−1(k
∗
1 , . . . , k
∗
I )
are shown in Table 3.
Generally, with respect to stratum (k∗1 , . . . , k
∗
I ) in which the new patient
falls, we will divide the m=
∏i
i=1mi strata into several categories and find
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Table 3
An example showing the weights of Dn−1(k1, . . . , kI)’s in δn−1(k
∗
1 , . . . , k
∗
I )
Stratum Description Weight
1 (1,1,1) male smokers at center 1 wo +wm,1 +wm,2 +wm,3 +ws = 1
2 (1,1,2) male smokers at center 2 wo +wm,1 +wm,2
3 (1,1,3) male smokers at center 3 wo +wm,1 +wm,2
4 (1,2,1) male nonsmokers at center 1 wo +wm,1 +wm,3
5 (2,1,1) female smokers at center 1 wo +wm,2 +wm,3
6 (1,2,2) male nonsmokers at center 2 wo +wm,1
7 (1,2,3) male nonsmokers at center 3 wo +wm,1
8 (2,1,2) female smokers at center 2 wo +wm,2
9 (2,1,3) female smokers at center 3 wo +wm,2
10 (2,2,1) female nonsmokers at center 1 wo +wm,3
11 (2,2,2) female nonsmokers at center 2 wo
12 (2,2,3) female nonsmokers at center 3 wo
out the corresponding weights in the expression of δn−1(k
∗
1 , . . . , k
∗
I ). Let I=
{1,2, . . . , I}. For any stratum (k1, . . . , kI):
- if (k1, . . . , kI) = (k
∗
1 , . . . , k
∗
I ), then the weight on Dn−1(k1, . . . , kI) is wo +∑I
i=1wm,i +ws = 1;
- for any fixed i (i ∈ I), if ki 6= k
∗
i and kj = k
∗
j for j ∈ I and j 6= i, then
the weight on Dn−1(k1, . . . , kI) is wo +
∑
j 6=iwm,j , and there are (mi − 1)
strata in this category;
- for any fixed i1 < i2 ({i1, i2} ⊂ I), if ki1 6= k
∗
i1
, ki2 6= k
∗
i2
, and kj = k
∗
j for
j ∈ I, j 6= i1 and j 6= i2, then the weight on Dn−1(k1, . . . , kI) is wo +∑
j 6=i1,j 6=i2
wm,j , and there are (mi1 − 1)(mi2 − 1) strata in this category;
- for any fixed i1 < i2 < · · · < il ({i1, . . . , il} ⊂ I), if kit 6= k
∗
it
and kj = k
∗
j
for j ∈ I, j 6= it and 1 ≤ t ≤ l, then the weight on Dn−1(k1, . . . , kI) is
wo+
∑
j 6=it,1≤t≤l
wm,j , and there are
∏l
t=1(mit−1) strata in this category;
- if ki 6= k
∗
i for all i ∈ I, then the weight on Dn−1(k1, . . . , kI) is wo, and there
are
∏l
i=1(mi − 1) strata in this category.
It is easily verified that
m=
I∏
i=1
mi
= [(m1 − 1) + 1][(m2 − 1) + 1] · · · [(mI − 1) + 1]
= 1+
I∑
l=1
∑
1≤i1<i2<···<il≤I
l∏
t=1
[mit − 1],
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which is consistent with the counts listed above. Our general theorem in the
following is closely related to the above weights and counts.
Theorem 3.2. For the new design, consider I covariates and mi levels
for the ith covariate, where I ≥ 1, 1≤ i≤ I, and mi > 1. wo, ws and wm,i,
i= 1, . . . , I, are nonnegative with wo +
∑I
i=1wm,i +ws = 1. If
u∗ :=
I∑
l=1
∑
1≤i1<i2<···<il≤I
{(
wo +
∑
j 6=it,1≤t≤l
wm,j
) l∏
t=1
[mit − 1]
}
< 1/2,(C)
then Dn is a positive recurrent Markov chain on Z
m.
To see the theorem in a more intuitive way, we will take a closer look at u∗
in the special case of two covariates, as is shown in the following corollary.
Corollary 3.2. In Theorem 3.2, if I = 2, then condition (C) is equiv-
alent to
(m1m2 − 1)wo + (m1 − 1)wm,2 + (m2 − 1)wm,1 < 1/2.(C
′)
Remark 3.4. When wo = 0 and wm,1 =wm,2 =wm, condition (C
′) fur-
ther reduces to wm < [2(m1+m2−2)]
−1. For example, if m1 =m2 = 5, then
wm < 1/16 is required to satisfy condition (C).
Remark 3.5. In both Theorems 3.1 and 3.2, ws > 0 is required. There-
fore, the theoretical results in these theorems do not apply to Pocock and
Simon’s (1975) design (with ws = 0). The simulation result in Table 4 (Sec-
tion 4) shows that the within-stratum imbalances under their method in-
crease as the sample size increases, suggesting that they may not have the
rate of Op(1). We hypothesize that the condition ws > 0 is critical to ensure
that (Dn)n≥1 is positive recurrent. These are further research problems.
To prove the above two theorems, we will use the technique of “drift
conditions” [Meyn and Tweedie (1993)], which was developed for Markov
chains on general state spaces. Applying their theory to our problem, in
order to prove positive recurrence of (Dn)n≥1 we need to find a test function
V :Zm → R+, a bounded test set C on Zm and two positive constants M1
and M2 such that
∆V (D) :=
∑
D′∈Zm
P (D,D′)V (D′)− V (D)(3.2)
satisfies the following two conditions:
∆V (D)≤−M1, D /∈ C,(3.3)
∆V (D)≤M2, D ∈ C,(3.4)
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where P (D,D′) is the transition probability from D to D′ on state space Zm
of the chain (Dn)n≥1. V is often a norm-like function on Z
m. These drift
conditions can roughly be interpreted as follows: so long as the average one-
step movement ∆V tends to go back (with the magnitude uniformly greater
than a positive constant M1), that is, the chain is pulled back toward the
finite set C, positive recurrence can be ensured. For proofs of the theorems,
see Section 6 and the supplemental article [Hu and Hu (2012)].
4. Simulation studies. We will compare the new procedure with strat-
ified permuted block randomization and Pocock and Simon’s (1975) mini-
mization method. The simulations can be divided into three parts. First, we
will simulate the case of 2× 2 strata with a relatively large number of pa-
tients, to verify the convergence rate as stated in Theorem 3.1. Secondly, we
are interested in the performances of different randomization methods when
the number of strata is large as compared to the sample size. An example of
500 patients and 10 covariates (each with 2 levels) will be studied. Finally,
an example from Toorawa et al. (2009) will be considered, which is chosen
because it resembles real situations in clinical trials.
4.1. 2×2 strata. For the three randomization procedures, we want to see
whether the imbalances at any of the three levels (within-stratum, marginal
and overall) stabilize, which indicates the rate of Op(1) at that specific level.
The parameters are specified as follows:
- Multinomial probability (p(1,1), p(1,2), p(2,1), p(2,2)) = (0.1,0.2,0.3,0.4).
- Biasing probability p= 0.85 and q = 0.15 for Pocock and Simon’s method
(PS) as well as for the new procedure (NEW).
- Block size 4 for stratified randomization (STR-PB).
- Sample size n= 200,500,1000; number of simulated trials N = 1000.
- NEW: (wo,wm,1,wm,2,ws) = (0.3,0.1,0.1,0.5); conditions (A) and (B) are
satisfied.
- PS: (wo,wm,1,wm,2,ws) = (0,0.5,0.5,0); Conditions (A) and (B) are NOT
satisfied.
Table 4 shows the standard deviations (std’s) of Dn(·)’s at different levels
(by symmetry of the designs, the theoretical mean of each Dn(·) is always 0).
For simplicity, only the result of 2 strata and 2 margins are listed. Of the
five columns, the first and the second give the std’s of assignment differences
within stratum (1,1) and (2,2); the third and fourth for the marginal dif-
ferences of covariate 1 at level 1 and covariate 2 at level 2; and the last for
the overall difference.
Table 4 suggests that all 5 standard deviations stabilize under NEW and
STR-PB when the sample size increases. For example, under NEW the std’s
of Dn(1,1) are 1.11, 1.14 and 1.03; and those of Dn are 1.32, 1.22 and
1.27, which means that our new procedure preserves the rate of Op(1). The
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Table 4
std’s of Dn(·) of several methods under different sample sizes
Sample size Dn(1,1) Dn(2,2) Dn(1; 1) Dn(2; 2) Dn
STR-PB 200 0.92 0.89 1.30 1.27 1.83
500 0.92 0.92 1.31 1.30 1.86
1000 0.92 0.89 1.31 1.28 1.81
PS 200 3.16 3.27 1.15 1.13 1.30
500 4.80 4.83 1.16 1.11 1.31
1000 7.25 7.33 1.15 1.13 1.30
NEW 200 1.11 1.07 1.30 1.27 1.32
500 1.14 1.10 1.33 1.28 1.22
1000 1.03 1.10 1.20 1.24 1.27
same conclusion can be reached for STR-PB. In fact, since the block size
is 4, any within-stratum imbalance under STR-PB is bounded by 2. For PS,
however, while the std’s of marginal and overall differences stabilize, those
of the within-stratum differences do not. For example, the std of Dn(1,1)
increases from 3.16 to 4.80 and 7.25, much larger than those under the other
two methods.
For the within-stratum imbalances, STR-PB is the best [0.92 forDn(1,1)],
with NEW having slightly larger std’s and PS the largest. For the marginal
imbalances, PS is the best [around 1.15 for Dn(1; 1)], and the other two are
about the same [around 1.30 for Dn(1; 1)]. For the overall imbalance, STR-
PB is not as good as NEW and PS. Therefore, we see that even for 4 strata,
STR-PB does not perform well for the overall imbalance.
4.2. 210 strata. We simulate a hypothetical trial, which involves 500 pa-
tients, 10 covariates and 2 levels for each, that is, 1024 strata in total. The
biased coin probabilities p and q for NEW and PS, the block size for STR-
PB and the number of simulated trials N remain the same. The covariates
are generated as follows: in addition to the independence assumption of co-
variates between patients, we further assume that within each patient the
different covariates are independent and that each level within a fixed co-
variate is equally likely. Therefore, for the covariate profile Zi = (k1, . . . , kI)
of the ith patient, k1, . . . , kI are independently sampled from {1,2}. For the
weights, we use wo = 0, ws = 0.5 and wm,i = 0.5/10.
Of the 1024 strata, on average 61.4% have no patient, and only 0.1% have
4 or more. Hence, if STR-PB is employed, most blocks are incomplete, which
tends to cause large overall imbalance. Table 5 displays the mean absolute
imbalances under each of the three randomization methods.
As seen in Table 5, STR-PB has an extremely large E|Dn| (17.07). In
comparison, the other two methods have much smaller values of 0.76 and
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Table 5
Mean |Dn(·)| for 2
10 strata and 500 patients
STR-PB PS NEW
Overall 17.07 0.76 0.98
Marginal 11.80 1.65 1.94
Within-strt. (2 pts) 0.66 0.98 0.50
Within-strt. (3 pts) 1.00 1.23 1.08
0.98. So in this respect, PS has the best performance, and NEW is only
slightly worse. In the second row, the mean absolute marginal imbalance is
the average of the absolute differences over 20 margins as well as over the
1000 simulations, and the interpretation is the same as the overall imbalance.
For the within-stratum imbalances, the table shows the result for strata with
2 or 3 patients. For example, under PS, 0.98 is the mean absolute difference
over all strata with 2 patients as well as over the 1000 simulations. Under
this criterion, PS is not recommended since the two means are 0.98 and 1.23,
the largest among the three methods. STR-PB and NEW are quite similar,
with means 0.66 versus 0.50 for strata with 2 patients, and 1.00 versus 1.08
with 3 patients. Hence, although our new procedure is not always the best,
it ensures that no single type of the imbalances becomes too extreme.
4.3. An example mimicking real clinical data. We chose an example from
Toorawa et al. (2009). The four covariates are site, gender, age and disease
status, with 20, 2, 2 and 2 levels, respectively, resulting in 160 strata. The
covariates’ distribution is replicated in Table 6, where the marginal distri-
bution of sites is independent of the joint distribution of the remaining three
covariates.
Table 6
Distribution of covariates
Sites Small (2 sites) 1/120
Medium (16 sites) 6/120
Large (2 sites) 11/120
Other 3 covariates Male; < 60; Moderate disease 10/20
Male; ≥ 60; Moderate disease 2/20
Male; < 60; Severe disease 2/20
Male; ≥ 60; Severe disease 2/20
Female; < 60; Moderate disease 1/20
Female; ≥ 60; Moderate disease 1/20
Female; < 60; Severe disease 1/20
Female; ≥ 60; Severe disease 1/20
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Table 7
Distribution of patients among 160 strata
# of pts within stratum 0 1 2 3 4 and more
# of strata 95.4 38.8 12.7 5.6 7.6
Proportion 59.6% 24.3% 7.9% 3.5% 4.7%
120 patients enter the trial sequentially, and their covariates are indepen-
dently simulated from the multinomial distribution in Table 6. We use the
same p, q and block size as in the previous two examples. The weights are
specified in the following way:
- NEW: wo =ws = 1/3 and wm,i = 1/12, i= 1, . . . ,4.
- PS: wo =ws = 0 and wm,i = 1/4, i= 1, . . . ,4.
Table 7 shows the distribution of 120 patients among 160 strata. In this
case 24.3% of the strata have 1 patient; 11.4% contain 2 or 3 patients. If
stratified randomization is employed, then the patients in the above 24.3%
strata has to be randomized by equal probabilities. Moreover, the incomplete
blocks in strata with 2 or 3 patients also pose a high risk of large overall
imbalance.
The mean absolute imbalances at the three levels are compared, as shown
in Tables 8, 9 and 10. Table 8 shows the result for the overall imbalance
and lists the mean, median and 95% quantile of |D120|. It is seen that NEW
has mean, median and 95% quantile of 0.63, 0 and 2, respectively, whereas
PS has slightly higher values. The three quantities are extremely high under
STR-PB, which are not recommended for this case.
Table 9 gives the mean absolute marginal imbalances. For the covariates
of gender, age and disease, the table explicitly lists the mean values on
these 6 margins, as each of them only has two levels. For example, over
the 1000 simulations, on average the absolute differences of patients in the
two treatment groups within all male are 5.52, 1.10 and 1.59 under STR-
PB, PS and NEW, respectively. Therefore, in this respect PS has the best
performance; NEW is slightly worse, but still tolerable; STR-PB is the worst,
since its mean is as high as 5.52. Similar conclusions can be reached for the
Table 8
Comparison of absolute overall imbalance |Dn|
STR-PB PS NEW
Mean 6.70 0.91 0.63
Median 6 0 0
95% quan 16 2 2
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Table 9
Comparison of mean absolute marginal imbalances E|Dn(i;ki)|
STR-PB PS NEW
Gender male 5.52 1.10 1.59
female 3.86 1.06 1.55
Age < 60 4.84 1.08 1.57
≥ 60 4.40 1.11 1.23
Disease moderate 5.01 1.10 1.56
severe 4.35 1.18 1.52
20 sites 2 small 1.45 0.94 1.02
16 median 1.44 1.21 1.32
2 large 1.47 1.33 1.52
other 5 margins. Moreover, for the margins relating to “site,” since there
are a total of 20 margins, we are unable to show the result on each margin
due to the space limit. Hence, these 20 margins are further categorized into
three groups of small, median and large sizes, and the mean values in the
table are further averaged over the margins within the groups. For example,
1.32 is the mean absolute imbalance over the 16 median-sized sites as well as
over the 1000 simulations. In terms of imbalances on margins defined by site,
PS is still the best, and STR-PB has similar performance to NEW. This is
because each margin of site contains only 8 strata, hence the “accumulating
effect” of within-stratum imbalances under STR-PB is not as strong.
Table 10 displays the distribution and absolute mean of within-stratum
imbalances for strata with 2 or 3 patients. For example, of all the strata
which contain 2 patients, the absolute difference is either 0 or 2, and the
distribution is 0.69 to 0 and 0.31 to 2 under NEW, leading to an average
of 0.62. According to this criterion, NEW has the lowest mean, STR-PB
has a slightly larger value and PS has mean as large as 0.86. For strata
containing 3 patients, since the block size is 4 for STR-PB, it is impossible
Table 10
Comparison of absolute within-stratum imbalances |Dn(k1, . . . , kI)|: Distribution and mean
# of pts’ within strt. |Dn(k1, . . . , kI)| STR-PB PS NEW
2 prob(= 0) 0.68 0.57 0.69
prob(= 2) 0.32 0.43 0.31
mean 0.64 0.86 0.62
3 prob(= 1) 1.00 0.85 0.94
prob(= 3) 0.00 0.15 0.06
mean 1.00 1.30 1.12
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to get an absolute value of 3. Hence, the mean absolute imbalance is 1, the
minimum among the three methods.
In summary, our new method maintains good balance from all three per-
spectives and should be favored. We also performed the simulations under
other parameter values. Some of them include: (1) changing the weights wo,
ws, and wm,i, as well as the block size; (2) 2× 100 strata, representing few
covariates but many levels at least for one covariate; (3) 3× 4× 5× 6 strata,
representing a few covariates and a few levels for each. In all the above
settings, our new procedure shows advantages over the other two methods.
5. Conclusion. In this paper we propose a new covariate-adaptive design
that minimizes a weighted average of three types of imbalances (within-
stratum, within-covariate-margin and overall). Simulation results show that
the proposed method provides better allocation balance from different per-
spectives, while stratified randomization and Pocock and Simon’s (1975)
marginal method have large imbalances either as a whole, or within-stratum.
The new procedure can also be generalized in several ways. In this pa-
per we only considered balanced allocation (1:1), whereas in some problems
unequal ratios [Hu and Rosenberger (2006)] are also desired. For example,
if the two groups are an innovation versus a placebo, and a pilot study has
shown some effect of the innovation, then it is more ethical to assign more
patients to the innovation. If one treatment is much more costly than the
other, then assigning more patients to the latter would be more economi-
cal. Sometimes, the randomization has to be adapted to covariates as well
as responses. Zhang et al. (2007) proposed “covariate-adjusted response-
adaptive randomization,” whose allocation ratio depends on both covariate
profiles and responses of patients. One may modify our proposed procedure
to accommodate these situations. On the other hand, some trials (e.g., some
Phase II trials) involve the comparison of more than two treatments [Pocock
and Simon (1975), Hu and Rosenberger (2006), etc.]. We can generalize the
proposed procedure to clinical trials for comparing three or more treatments.
We leave these as future research topics.
For Efron’s (1971) biased coin design (without involving covariates), it
is well known that the imbalance is a positive recurrent Markov chain.
Markaryan and Rosenberger (2010) studied some exact properties of Efron’s
(1971) biased coin design. However, to our best knowledge, there is no the-
oretical result about the imbalance of covariate-adaptive randomization in
literature, due to the complex of the problem and the lack of technical tools.
In this paper, we introduced the technique of “drift conditions” in Markov
chains to study the theoretical properties of covariate-adaptive randomiza-
tion. This technique could provide a possible way of studying the properties
of general covariate-adaptive designs as well as covariate-adjusted response-
adaptive designs.
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The inference under covariate-adaptive randomization is also an impor-
tant issue. By simulation studies, several authors have raised concerns about
the conservativeness of the unadjusted analysis (such as two-sample t-test)
under covariate-adaptive randomization and suggested that all covariates
that are used in the randomization should be included in the analysis [Bir-
kett (1985), Forsythe (1987), etc.]. Shao, Yu and Zhong (2010) studied the
theoretical relationship between different randomization designs and differ-
ent inference methods. To make the problem more tractable, the authors
focused on a simple homogeneous linear model. They found that if the un-
derlying response-covariate model can be correctly specified, then the usual
regression analysis is valid and has the highest power as compared to other
types of analysis, no matter what randomization is employed. These results
also apply to the proposed randomization procedure in this paper.
If the model specification is not feasible and only a two-sample t-test
can be used, then the test under stratified randomization tends to have
a conservative type I error rate due to the overestimation of Var(Y¯1 − Y¯2).
Shao, Yu and Zhong (2010) used a bootstrap method to correct the variance
estimation. The resulting bootstrap t-test restores the type I error rate, and
is more powerful than the traditional t-test under simple randomization.
Similar bootstrap adjustment can be used as an inference method for the
new randomization procedure. We leave this as a future research project.
6. Sketch of proofs.
Proof of Theorem 3.1. With 2×2 strata, the within-stratum imbal-
ances Dn and the multinomial probabilities p are both matrices of 2×2. Let
D˜n = (Dn,1,Dn,2,Dn,3,Dn,4) := (Dn(1,1),Dn(1,2),Dn(2,1),Dn(2,2)), that
is, D˜n is simply the vector form of Dn. p˜= (p1, . . . , p4) can be defined in the
same way. By the above notation, any stratum can be represented by the
2-index form (k1, k2), or the single-index form (r) (1≤ r ≤ 4). The quantity
δn−1(k
∗
1 , k
∗
2) in (3.1) then reduces to
δn−1(k
∗
1, k
∗
2)
= (wo +wm,1 +wm,2 +wo)Dn−1(k
∗
1, k
∗
2) + (wo +wm,1)Dn−1(k
∗
1, k2)
(6.1)
+ (wo +wm,2)Dn−1(k1, k
∗
2) +woDn−1(k1, k2)
= u1Dn−1(k
∗
1 , k
∗
2) + u2Dn−1(k
∗
1 , k2) + u3Dn−1(k1, k
∗
2) + u4Dn−1(k1, k2),
where k1 6= k
∗
1 , k2 6= k
∗
2 and u1 = 1. Let δ˜n = (δn,1, δn,2, δn,3, δn,4) := (δn(1,1),
δn(1,2), δn(2,1), δn(2,2)). Then, according to (6.1), D˜n and δ˜n are linked by
δ˜n = D˜n


u1 u2 u3 u4
u2 u1 u4 u3
u3 u4 u1 u2
u4 u3 u2 u1

 := D˜nU.(6.2)
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For any D˜n ∈ Z
4, we define a test function
V (D˜n) =
4∑
r=1
[Dn,r]
2
pr
,
that is, the sum of squared within-stratum differences adjusted for the
corresponding multinomial probabilities. The test set C is defined as C =
{D˜n :maxr ‖D˜n,r‖ ≤K} (K > 0 is to be determined). V and C are the key el-
ements in proving positive recurrence, according to the drift conditions (3.3)
and (3.4).
For the ease of representation, in the rest of the proof we will simply use
the notation D and δ for D˜n and δ˜n, respectively, unless specified otherwise.
Under the new allocation rule, it can be derived that the one-step movement
∆V (D), defined in (3.2), has the form
∆V (D) = 2(q − p)
4∑
r=1
sgn(δr)Dr + 4,
where Dr and δr are the rth element of vectors D and δ, respectively,
and sgn(x) = 1, −1, 0 for x > 0, < 0 or = 0. For derivation of ∆V (D), see
Section 1 of the supplemental article [Hu and Hu (2012)].
We need to show that ∆V (D) satisfies drift conditions (3.3) and (3.4). In
fact, since the test set C is bounded, (3.4) is trivially true. Since q − p < 0,
(3.3) is equivalent to finding M ′1 > 2/(p− q) such that
∆W (D) :=
4∑
r=1
sgn(δr)Dr >M
′
1 for D /∈ C.(6.3)
Intuitively, when u2, u3 and u4 are small, δr is expected to be close to Dr
so that they have the same sign. Thus, a larger proportion of the strata
have sgn(δr)Dr = sgn(Dr)Dr = |Dr| and ∆W (D) tends to be positive. In
the trivial case that u2 = u3 = u4 = 0, that is, D = δ, we have ∆W (D) =∑4
r=1 |Dr|>K, so (6.3) holds by letting M
′
1 =K = 2.1/(p − q). Therefore,
in the following we can assume that max{u2, u3, u4}> 0.
For any D ∈ Cc ⊂ Z4, call the pair of (Dr, δr) a “match” if δr 6= 0 and
δrDr ≥ 0. Hence, for a match sgn(δr)Dr = |Dr|. Furthermore, defineM(D,δ)
as the number of matches in (Dr, δr)’s, r = 1, . . . ,4. Obviously, 0≤M(D,δ)≤
4. It can be shown that M(D,δ) = 0 is impossible for D ∈ Cc. Therefore, for
M(D,δ) = i, i = 1,2,3,4, if we can find di > 0, such that ∆W (D) > diK,
then (6.3) is true by letting M ′1 =Kmini di and K = 2.1/[(p− q)mini di].
In fact, finding d4 for M(D,δ) = 4 is quite trivial (d4 = 1). We will show
how to find d3 forM(D,δ) = 3 below. WhenM(D,δ) = 3, we know that a1 =
max{u2, u3, u4} 6= 0 and a2 =min{1− u2,1− u3,1− u4} 6= 0 (since ws 6= 0).
Without loss of generality assume D1 and δ1 do not match, which means
δ1D1 ≤ 0. Thus |δ1 −D1| ≥ |D1|. By (6.2), δ1 −D1 = u2D2 + u3D3 + u4D4,
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which implies |u2D2 + u3D3 + u4D4| ≥ |D1|. Then
∆W (D)≥−|D1|+ |D2|+ |D3|+ |D4|
≥ −(u2|D2|+ u3|D3|+ u4|D4|) + |D2|+ |D3|+ |D4|
≥ a2(|D2|+ |D3|+ |D4|)
≥ a2[(1/2)(|D2|+ |D3|+ |D4|) + (1/2)a
−1
1 |D1|]
≥ (a2/2)min{1, a
−1
1 } ·max{|D1|, |D2|, |D3|, |D4|}
> (a2/2)min{1, a
−1
1 } ·K := d3K.
The ways of finding d2 and d1 for M(D,δ) = 2 and 1 are similar, but require
more work. In particular, condition (B) in Theorem (3.1) is needed to verify
the case ofM(D,δ) = 1. In Section 2 of the supplemental article [Hu and Hu
(2012)], we show how to find di for i= 4,3,2,1 and explain whyM(D,δ) 6= 0.
Corollary 3.1 is obtained by solving the linear equation for x in Theo-
rem 3.1 under the assumption that wm,1 = wm,2 and then substituting the
solution in |x1| + |x2| + |x3| < 1. For detailed proof of Corollary 3.1, see
Section 3 of the supplemental article [Hu and Hu (2012)]. 
Proof of Theorem 3.2. The main steps are similar to those in Theo-
rem 3.1. Let D˜n = (Dn,1, . . . ,Dn,m) be the vector version ofDn = (Dn(k1, . . . ,
kI)), where the m strata can be arbitrarily ordered and indexed by 1, . . . ,m.
Similary, let δ˜n and p˜ be the vector forms of array (δn(k1, . . . , kI)) and array
(p(k1, . . . , kI)), respectively, using the same order as in (Dn(1), . . . ,Dn(m)).
By the above notation, any stratum can be represented by the I-index form
(k1, . . . , kI), or the single-index form (r) (1≤ r ≤m). As in the 2× 2 case,
let δ˜n := D˜nU. Then by the definition of δ˜n as well as the description
of weights before Theorem 3.2, for any two strata (r) = (k∗1 , . . . , k
∗
I ) and
(s) = (k1, . . . , kI), the element urs in the matrix of U is determined as fol-
lows: for any fixed i1 < i2 < · · ·< il ({i1, . . . , il} ∈ I), if kit 6= k
∗
it
and kj = k
∗
j
for j ∈ I, j 6= it and 1≤ t≤ l, then
urs =wo +
∑
j 6=it,1≤t≤l
wm,j .
So urs = usr, and for any r,
∑
s=1,...,m,s 6=r urs = u
∗, as defined in Theorem 3.2.
The test function V and the test set C are still defined as before, except
that in this case the dimension of D˜n is m instead of 4. Use the simple
notation D and δ for D˜n and δ˜n, respectively. In the same manner, to
verify the drift conditions it is equivalent to find M ′1 > 2/(p− q) such that
∆W (D) :=
m∑
r=1
sgn(δr)Dr >M
′
1 for D /∈ C.(6.4)
For any fixed D ∈ Cc ⊂ Zm, suppose for (Dr, δr)’s, r = 1, . . . ,m, there are m0
mismatched pairs. Without loss of generality assume that the mismatched
pairs occur in the 1st, 2nd, . . . and the m0th strata. By the definition of
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a mismatched pair, Dr and δr =
∑r−1
s=1 ursDs + Dr +
∑m
s=l+1 ursDs have
different signs, r = 1, . . . ,m0. Therefore,
|Dr| ≤
∣∣∣∣∣
r−1∑
s=1
ursDs +
m∑
s=l+1
ursDs
∣∣∣∣∣
(6.5)
≤
∑
s=1,...,m0,s 6=r
urs|Ds|+
m∑
s=m0+1
urs|Ds|.
First, we notice that m0 6=m; otherwise, by summing (6.5) over r= 1 to m,
we have
∑m
r=1 |Dr| ≤ u
∗
∑m
r=1 |Dr| which is impossible for D ∈ C
c and u∗ <
1/2. Second, suppose m0 6=0. By summing (6.5) over r=1 to r=m0, we have
m0∑
r=1
(
1−
∑
s=1,...,m0,s 6=r
urs
)
|Dr| ≤
m∑
r=m0+1
(
m0∑
s=1
urs
)
|Dr|.
Combined with the fact that 1−u∗ ≤ (1−
∑
s=1,...,m0,k 6=r
urs) for r= 1, . . . ,m0
and (
∑m0
s=1 urs)≤ u
∗ for r=m0 +1, . . . ,m, it is seen that
m0∑
r=1
(1− u∗)|Dr| ≤
m∑
r=m0+1
u∗|Dr|.
Then
∆W (D)≥−|D1| − |D2| − · · · − |Dm0 |+ |Dm0+1|+ |Dm0+2|+ · · ·+ |Dm|
≥ −
u∗
1− u∗
m∑
r=m0+1
|Dr|+
m∑
r=m0+1
|Dr|=
(
1−
u∗
1− u∗
) m∑
r=m0+1
|Dr|.
Since 0 ≤ u∗ < 1/2, we have 0 < 1 − u
∗
1−u∗ ≤ 1. Hence, the above inequal-
ity is also true for m0 = 0. If maxm0+1≤r≤m |Dr|>K, then ∆W (D)> (1−
u∗
1−u∗ )K; otherwise max1≤r≤m0 |Dr|>K and
∑m
r=m0+1
|Dr| ≥
1−u∗
u∗
∑m0
r=1 |Dr|,
which means ∆W (D)> (1− u
∗
1−u∗ )
1−u∗
u∗
K > (1− u
∗
1−u∗ )K. Thus, if we define
M ′2 = (1−
u∗
1−u∗ )K and K =
2.1
p−q
(1− u
∗
1−u∗ )
−1, then
∆W (D)>M ′2 > 2/(p− q). 
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SUPPLEMENTARY MATERIAL
Additional proofs (DOI: 10.1214/12-AOS983SUPP; .pdf). We provide ad-
ditional proofs that are omitted in Section 6. They include: (1) derivation
of ∆V (D); (2) the appropriate choice of di when M(D,δ) = i (i= 4,3,2,1);
(3) proof of Corollary 3.1.
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